Flu vaccine strategy on the line as new US leaders anticipated to take charge
Public health experts are anticipating a changing discourse following RFK Jr’s appointment as head of HHS.
Regulation
Reprieve for Chinese biotechs as BIOSECURE Act left out of key bill
FDA shares new draft guidance for accelerated approval
FDA’s Marks says RFK Jr dialogue gives chance to have “lies debunked” on vaccines
BMS CFO backs “resilient” pharma industry amid RFK Jr’s impending governance
LakeShore commences BLA submission to DRAP for rabies vaccine
US Border Protection warns pharma of risks with incorrect biologic importation
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
